InvestorsHub Logo

Protector

07/25/16 6:33 AM

#268921 RE: exwannabe #268897

exwannebee, there are 18 enrolled of the 20 intended in the Yervoy+Bavituximab. Results for 2016. Enrolment stopped because SOC changed for melanoma.